Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03461952
Status:
TERMINATED
Last Update Posted:
2024-02-22
First Post:
2018-03-05
Brief Title:
Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood NIMBLe
Sponsor:
Canadian Cancer Trials Group
Organization:
Canadian Cancer Trials Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-05
First Submit QC Date:
March 5 2018
Study First Post Date:
2018-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-20
Last Update Post Date:
2024-02-22
Last Update Post Date Type:
ACTUAL